Zengwu Shao

664 total citations
21 papers, 478 citations indexed

About

Zengwu Shao is a scholar working on Pathology and Forensic Medicine, Pharmacology and Molecular Biology. According to data from OpenAlex, Zengwu Shao has authored 21 papers receiving a total of 478 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pathology and Forensic Medicine, 8 papers in Pharmacology and 6 papers in Molecular Biology. Recurrent topics in Zengwu Shao's work include Spine and Intervertebral Disc Pathology (9 papers), Musculoskeletal pain and rehabilitation (7 papers) and Osteoarthritis Treatment and Mechanisms (4 papers). Zengwu Shao is often cited by papers focused on Spine and Intervertebral Disc Pathology (9 papers), Musculoskeletal pain and rehabilitation (7 papers) and Osteoarthritis Treatment and Mechanisms (4 papers). Zengwu Shao collaborates with scholars based in China, United States and Israel. Zengwu Shao's co-authors include Sheng Chen, Kuo‐Hsing Ma, Libo Zhao, Simin Liu, Hui Lin, Xin Huang, Shengli Mi, Wei Sun, Ming Li and Bin Kong and has published in prestigious journals such as Nature Communications, Advanced Functional Materials and Scientific Reports.

In The Last Decade

Zengwu Shao

18 papers receiving 475 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zengwu Shao China 10 173 134 123 87 80 21 478
Hui Tao China 13 216 1.2× 80 0.6× 112 0.9× 153 1.8× 54 0.7× 33 415
Feng‐Juan Lyu China 9 213 1.2× 190 1.4× 160 1.3× 99 1.1× 52 0.7× 19 555
Haoruo Jia China 13 170 1.0× 179 1.3× 137 1.1× 138 1.6× 68 0.8× 20 584
Sonja Häckel Switzerland 11 205 1.2× 123 0.9× 109 0.9× 169 1.9× 66 0.8× 39 491
Joan Fitzgerald Ireland 6 171 1.0× 94 0.7× 115 0.9× 96 1.1× 69 0.9× 9 378
Masaaki Uesugi Japan 13 97 0.6× 78 0.6× 79 0.6× 214 2.5× 28 0.3× 20 473
Yuanwu Cao China 13 217 1.3× 117 0.9× 70 0.6× 164 1.9× 98 1.2× 34 448
Dasheng Tian China 15 267 1.5× 103 0.8× 37 0.3× 256 2.9× 62 0.8× 44 562
Bo Han China 17 219 1.3× 282 2.1× 59 0.5× 290 3.3× 100 1.3× 62 880
Hideki Nakamoto Japan 12 124 0.7× 156 1.2× 105 0.9× 194 2.2× 60 0.8× 40 601

Countries citing papers authored by Zengwu Shao

Since Specialization
Citations

This map shows the geographic impact of Zengwu Shao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zengwu Shao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zengwu Shao more than expected).

Fields of papers citing papers by Zengwu Shao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zengwu Shao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zengwu Shao. The network helps show where Zengwu Shao may publish in the future.

Co-authorship network of co-authors of Zengwu Shao

This figure shows the co-authorship network connecting the top 25 collaborators of Zengwu Shao. A scholar is included among the top collaborators of Zengwu Shao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zengwu Shao. Zengwu Shao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Kanglu, et al.. (2025). Tumor microenvironment in osteosarcoma: From cellular mechanism to clinical therapy. Genes & Diseases. 12(5). 101569–101569.
3.
Hu, Yuxiang, Wei Chen, Shenghui Lan, et al.. (2025). Denosumab attenuates knee osteoarthritis progression by inhibiting synovial inflammation via the RANK/TRAF6/FSTL1 signalling. Nature Communications. 16(1). 11394–11394.
4.
Zhang, Shuo, Binwu Hu, Xiangcheng Qing, et al.. (2024). Implications of circadian disruption on intervertebral disc degeneration: The mediating role of sympathetic nervous system. Ageing Research Reviews. 104. 102633–102633. 2 indexed citations
5.
Hu, Binwu, Peng Wang, Shuo Zhang, et al.. (2022). HSP70 attenuates compression-induced apoptosis of nucleus pulposus cells by suppressing mitochondrial fission via upregulating the expression of SIRT3. Experimental & Molecular Medicine. 54(3). 309–323. 42 indexed citations
6.
Yang, Fan, Yanbin Zhang, Sheng Liu, et al.. (2022). Tunneling Nanotube‐Mediated Mitochondrial Transfer Rescues Nucleus Pulposus Cells from Mitochondrial Dysfunction and Apoptosis. Oxidative Medicine and Cellular Longevity. 2022(1). 3613319–3613319. 33 indexed citations
7.
Chen, Sheng, Xiaohao Wu, Yumei Lai, et al.. (2022). Kindlin-2 inhibits Nlrp3 inflammasome activation in nucleus pulposus to maintain homeostasis of the intervertebral disc. Bone Research. 10(1). 5–5. 71 indexed citations
8.
Huang, Xin, Haoyu Guo, Lutong Wang, et al.. (2021). Exosomes as Efficient Nanocarriers in Osteosarcoma: Biological Functions and Potential Clinical Applications. Frontiers in Cell and Developmental Biology. 9. 737314–737314. 20 indexed citations
11.
Huang, Xin, Wei Wu, Wenbo Yang, Xiangcheng Qing, & Zengwu Shao. (2020). Surface engineering of nanoparticles with ligands for targeted delivery to osteosarcoma. Colloids and Surfaces B Biointerfaces. 190. 110891–110891. 31 indexed citations
12.
Wang, Jieqiong, Yun Chen, Ying Bai, et al.. (2020). A core-skirt designed artificial cornea with orthogonal microfiber grid scaffold. Experimental Eye Research. 195. 108037–108037. 6 indexed citations
13.
Huang, Xin, Wenbo Yang, Zhicai Zhang, & Zengwu Shao. (2019). Dysregulated circRNAs serve as prognostic and diagnostic markers in osteosarcoma by sponging microRNA to regulate the downstream signaling pathway. Journal of Cellular Biochemistry. 121(2). 1834–1841. 9 indexed citations
14.
Chen, Sheng, Simin Liu, Kuo‐Hsing Ma, et al.. (2019). TGF-β signaling in intervertebral disc health and disease. Osteoarthritis and Cartilage. 27(8). 1109–1117. 115 indexed citations
15.
Huang, Donghua, Xiangyu Deng, Kaige Ma, et al.. (2018). Association of COL9A3 trp3 polymorphism with intervertebral disk degeneration: a meta-analysis. BMC Musculoskeletal Disorders. 19(1). 381–381. 7 indexed citations
16.
Huang, Xin, Weiyue Zhang, & Zengwu Shao. (2018). Association between GDF5 rs143383 genetic polymorphism and musculoskeletal degenerative diseases susceptibility: a meta-analysis. BMC Medical Genetics. 19(1). 169–169. 11 indexed citations
18.
Kong, Bin, et al.. (2017). Tissue-engineered cornea constructed with compressed collagen and laser-perforated electrospun mat. Scientific Reports. 7(1). 970–970. 83 indexed citations
19.
Mu, Rong, Chunde Bao, Zhiwei Chen, et al.. (2014). Efficacy and safety of loxoprofen hydrogel patch versus loxoprofen tablet in patients with knee osteoarthritis: a randomized controlled non-inferiority trial. Clinical Rheumatology. 35(1). 165–173. 21 indexed citations
20.
Fan, Lei, Qiang Wu, Xiaojuan Xing, Yudong Liu, & Zengwu Shao. (2011). Targeted silencing of heparanase gene by small interfering RNA inhibits invasiveness and metastasis of osteosarcoma cells. Journal of Huazhong University of Science and Technology [Medical Sciences]. 31(3). 348–352. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026